B · Normal
[AI pharmaceutical concept fluctuated and rebounded, Berry Genetics hit the daily limit] On November 12, the AI ​​pharmaceutical concept fluctuated and rebounded during the session, Berry Genetics hit the daily limit, Biocytogen, Wanbang Pharmaceuticals, Presidium, Biopsis, Chengdu Pioneer, and Haoyuan Pharmaceutical followed suit. On the news, Anthropic CEO Dario Amodei recently stated in the company’s IPO roadshow video that he believes cancer, Alzheimer’s disease, heart disease and mental illness may become a thing of the past in less than 10 years. Previously, Amodei said that AI is expected to help find treatments for most cancers, prevent Alzheimer's disease, and even double human lifespan in the future.
Live broadcast 🕐 2026-11-12 10:32
#Anthropic #Gene #Live broadcast #AI medical #Chengdu Pioneer
Save as Image Generate a beautiful long image to share on Moments or in group chats Generate now ⬇
← Back to Telegraph

Related telegraphs

【主力资金监控：蓝色光标净买入超20亿】11月12日电，盯盘数据显示，今日早盘主力资金净流入半导体、电子、电子化学品等板块，净流出有色金属、电新行业、交运设备等 11-12 10:55 [The transaction volume of the Shanghai and Shenzhen stock markets exceeded 1 tr 11-12 10:53 [Cambrian rises by more than 13% and regains the 1,000 yuan mark] On November 12 11-12 10:18 [Suiyuan Technology rose by more than 15% to hit a new listing high, with a cumu 11-12 10:11 [The GEM Index rose by more than 1%, and the Science and Technology Innovation 5 11-12 10:05 [Semiconductor equipment sector was active, Yitang shares rose nearly 10%] On No 11-12 10:02

Comments

0/500
Captcha (click to refresh)
No comments yet